| Pharmaceutical active ingredients: |
| Enalapril MaleateLercanidipine Hydrochloride |
| Available forms, composition and doses of Lercapress: |
| Tablets, Film-Coated; Oral; Enalapril Maleate 20 mg; Lercanidipine Hydrochloride 10 mg |
| Lercapress medical category: |
| Human |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| C09BB02 - Enalapril and lercanidipine |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Pierre Fabre |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Vasoretic | Enalapril Maleate; Hydrochlorothiazide | Merck |
| Viviril-D | Enalapril Maleate; Hydrochlorothiazide | Sarabhai Piramal Pharma |
| Enzix | Enalapril Maleate; Indapamide | Hemofarm |
| Enzix Duo | Enalapril Maleate; Indapamide | Hemofarm |
| Enzix Duo Forte | Enalapril Maleate; Indapamide | Hemofarm |
| Zanextra | Enalapril Maleate; Lercanidipine Hydrochloride | Recordati |
| Envas-RB | Enalapril Maleate; Losartan Potassium | Cadila |
| LO-E | Enalapril Maleate; Losartan Potassium | East West Pharma |
| Eneas | Enalapril Maleate; Nitrendipine | Merck; Galenica, Greece; Grupo Vita / Vita Cientifica |
| Enit | Enalapril Maleate; Nitrendipine | Lacer |